Oregon Clinical Trials
Browse actively recruiting clinical trials with research sites in Oregon. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Oregon
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)Eugene, OR
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerBend, OR
- A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellPortland, OR
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerNCT07525206PHASE3AbbVieColorectal CancerPortland, OR
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyNCT07405086PHASE4OHSU Knight Cancer InstituteAdvanced Biliary Tract CarcinomaPortland, OR
- A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen SclerosusNCT07335588PHASE3LEO PharmaLichen SclerosusPortland, OR
- EMBRACE: Exercising TogetherNCT06049355PHASE2OHSU Knight Cancer InstituteBreast CarcinomaPortland, OR
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental VitiligoNCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoPortland, OR
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803PHASE3AstraZenecaWeight ManagementPortland, OR
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)NCT06312176PHASE3Merck Sharp & Dohme LLCBreast NeoplasmsPortland, OR
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)NCT07116967PHASE3Bristol-Myers SquibbPlaque PsoriasisMedford, OR
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisNCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisPortland, OR
Clinical trials by Oregon metro
Popular conditions in Oregon
Frequently asked questions
- How do I find clinical trials in Oregon?
- Corterve aggregates actively recruiting clinical trials with sites in Oregon from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Oregon free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Oregon?
- Oregon research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.